A detailed history of Hrt Financial LP transactions in Belite Bio, Inc stock. As of the latest transaction made, Hrt Financial LP holds 5,409 shares of BLTE stock, worth $378,089. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,409
Holding current value
$378,089
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$32.33 - $50.1 $174,872 - $270,990
5,409 New
5,409 $247,000

Others Institutions Holding BLTE

About BELITE BIO, INC


  • Ticker BLTE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,867,400
  • Market Cap $1.74B
  • Description
  • Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...
More about BLTE
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.